Evidence map›Paper›PMID 28208737›Full record

ArticleMolecules (Basel, Switzerland)2017

Special Issue on Ruthenium Complexes.

Ileana Dragutan, Valerian Dragutan, Albert Demonceau

Abstract readEditorial
In one paragraph

Article in Molecules (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Catalytically Active Light Printed Microstructures.Advanced materials (Deerfield Beach, Fla.) · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ileana DragutanInstitute of Organic Chemistry "C.D. Nenitescu", Romanian Academy, 202B Spl. Independentei, 060023 Bucharest, P.O. Box 35-108, Romania. idragutan@yahoo.com.
Valerian DragutanInstitute of Organic Chemistry "C.D. Nenitescu", Romanian Academy, 202B Spl. Independentei, 060023 Bucharest, P.O. Box 35-108, Romania. vdragutan@yahoo.com.
Albert DemonceauDepartment of Chemistry, University of Liège, Sart-Tilman (B.6a), 4000 Liège, Belgium. A.Demonceau@ulg.ac.be.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The organic chemistry of ruthenium has been one of the most vigorously growing research areas over the past decades. Considerable effort has been extended towards the design and application of a broad series of ruthenium complexes, which culminated with the development by Ryoji Noyori (2001 Nobel Prize for Chemistry) of chiral ruthenium catalysts for stereoselective hydrogenation reactions [1], and the discovery by Robert H. Grubbs (2005 Nobel Prize for Chemistry) of well-defined ruthenium- benzylidene catalysts for olefin metathesis [2] [...].

Indexed as

Chemistry, PharmaceuticalDrug DesignAnimalsDrug Delivery SystemsHumansRutheniumRuthenium

Identifiers

PMID28208737
PMCPMC6155890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.